What is it about?
The current study firstly indicates that MEF2A loss-of-function variation predisposes to DCM in humans.
Featured Image
Read the Original
This page is a summary of: Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy, Clinical Chemistry and Laboratory Medicine (CCLM), December 2020, De Gruyter,
DOI: 10.1515/cclm-2020-1318.
You can read the full text:
Contributors
The following have contributed to this page
